{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:59:03Z","timestamp":1791910743990,"version":"4.3.4"},"publisher-location":"Cham","reference-count":102,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031648380","type":"print"},{"value":"9783031648397","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-64839-7_13","type":"book-chapter","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T01:02:35Z","timestamp":1724720555000},"page":"319-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Role of Astrocytes in Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Roger","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"13_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2047-9158-4-4","volume":"4","author":"F Stocchi","year":"2015","unstructured":"Stocchi F, Vacca L, Radicati FG. How to optimize the treatment of early stage Parkinson\u2019s disease. Transl Neurodegener. 2015;4(1):4.","journal-title":"Transl Neurodegener"},{"issue":"6","key":"13_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD, Wade-Martins R. The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci. 2017;40(6):358\u201370.","journal-title":"Trends Neurosci"},{"key":"13_CR4","doi-asserted-by":"crossref","unstructured":"Baldwin KT, Murai KK, Khakh BS. Astrocyte Morphology. Trends Cell Biol. 2023;34(7):547\u2013565.","DOI":"10.1016\/j.tcb.2023.09.006"},{"issue":"2","key":"13_CR5","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"13_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"F Loria","year":"2017","unstructured":"Loria F, Vargas JY, Bousset L, Syan S, Salles A, Melki R, Zurzolo C. \u03b1-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol. 2017;134(5):789\u2013808.","journal-title":"Acta Neuropathol"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3233\/JPD-230284","volume":"13","author":"H Ozoran","year":"2023","unstructured":"Ozoran H, Srinivasan R. Astrocytes and alpha-synuclein: friend or foe? J Parkinsons Dis. 2023;13:1289\u2013301.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"13_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1006\/exnr.2002.7929","volume":"176","author":"F Mori","year":"2002","unstructured":"Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K. Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol. 2002;176(1):98\u2013104.","journal-title":"Exp Neurol"},{"issue":"9","key":"13_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1097\/00001756-200107030-00028","volume":"12","author":"K Tanji","year":"2001","unstructured":"Tanji K, Imaizumi T, Yoshida H, Mori F, Yoshimoto M, Satoh K, Wakabayashi K. Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta. Neuroreport. 2001;12(9):1909\u201312.","journal-title":"Neuroreport"},{"issue":"12","key":"13_CR10","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C, Bae EJ, Cho JH, Rho S, et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285(12):9262\u201372.","journal-title":"J Biol Chem"},{"issue":"45","key":"13_CR11","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1523\/JNEUROSCI.0954-20.2020","volume":"40","author":"T Tsunemi","year":"2020","unstructured":"Tsunemi T, Ishiguro Y, Yoroisaka A, Valdez C, Miyamoto K, Ishikawa K, et al. Astrocytes protect human dopaminergic neurons from \u03b1-synuclein accumulation and propagation. J Neurosci. 2020;40(45):8618\u201328.","journal-title":"J Neurosci"},{"issue":"49","key":"13_CR12","doi-asserted-by":"publisher","first-page":"11835","DOI":"10.1523\/JNEUROSCI.0983-17.2017","volume":"37","author":"J Rostami","year":"2017","unstructured":"Rostami J, Holmqvist S, Lindstr\u00f6m V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835\u201353.","journal-title":"J Neurosci"},{"issue":"1","key":"13_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","volume":"18","author":"J Rostami","year":"2021","unstructured":"Rostami J, Mothes T, Kolahdouzan M, Eriksson O, Moslem M, Bergstr\u00f6m J, et al. Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates. J Neuroinflammation. 2021;18(1):124.","journal-title":"J Neuroinflammation"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3389\/fphar.2019.01452","volume":"10","author":"A Venturini","year":"2019","unstructured":"Venturini A, Passalacqua M, Pelassa S, Pastorino F, Tedesco M, Cortese K, et al. Exosomes from astrocyte processes: signaling to neurons. Front Pharmacol. 2019;10:1452.","journal-title":"Front Pharmacol"},{"issue":"20","key":"13_CR15","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30(20):6838\u201351.","journal-title":"J Neurosci"},{"issue":"8","key":"13_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41419-021-04049-0","volume":"12","author":"TW Chou","year":"2021","unstructured":"Chou TW, Chang NP, Krishnagiri M, Patel AP, Lindman M, Angel JP, et al. Fibrillar \u03b1-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-\u03baB. Cell Death Dis. 2021;12(8):756.","journal-title":"Cell Death Dis"},{"issue":"12","key":"13_CR17","doi-asserted-by":"publisher","first-page":"108895","DOI":"10.1016\/j.celrep.2021.108895","volume":"34","author":"K Russ","year":"2021","unstructured":"Russ K, Teku G, Bousset L, Redeker V, Piel S, Savchenko E, et al. TNF-\u03b1 and \u03b1-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration. Cell Rep. 2021;34(12):108895.","journal-title":"Cell Rep"},{"issue":"11","key":"13_CR18","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.3390\/cells9112399","volume":"9","author":"A Navarro-Romero","year":"2020","unstructured":"Navarro-Romero A, Montpey\u00f3 M, Martinez-Vicente M. The emerging role of the lysosome in Parkinson\u2019s disease. Cells. 2020;9(11):2399.","journal-title":"Cells"},{"issue":"1","key":"13_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","volume":"4","author":"FM Platt","year":"2018","unstructured":"Platt FM, d\u2019Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Lysosomal storage diseases. Nat Rev Dis Primers. 2018;4(1):27.","journal-title":"Nat Rev Dis Primers"},{"key":"13_CR20","doi-asserted-by":"publisher","first-page":"104647","DOI":"10.1016\/j.nbd.2019.104647","volume":"134","author":"E Aflaki","year":"2020","unstructured":"Aflaki E, Stubblefield BK, McGlinchey RP, McMahon B, Ory DS, Sidransky E. A characterization of Gaucher iPS-derived astrocytes: potential implications for Parkinson\u2019s disease. Neurobiol Dis. 2020;134:104647.","journal-title":"Neurobiol Dis"},{"issue":"21","key":"13_CR21","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry AG, Aghamohammadzadeh S, Samaroo H, Chen Y, Mou K, Needle E, Hirst WD. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet. 2015;24(21):6013\u201328.","journal-title":"Hum Mol Genet"},{"issue":"Suppl 1","key":"13_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):216\u201331.","journal-title":"J Neurochem"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neuroscience.2011.08.016","volume":"196","author":"NJ Larsen","year":"2011","unstructured":"Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA. DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience. 2011;196:251\u201364.","journal-title":"Neuroscience"},{"issue":"Pt 2","key":"13_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain. 2004;127(Pt 2):420\u201330.","journal-title":"Brain"},{"issue":"10","key":"13_CR25","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","volume":"25","author":"BM Vincent","year":"2018","unstructured":"Vincent BM, Tardiff DF, Piotrowski JS, Aron R, Lucas MC, Chung CY, et al. Inhibiting stearoyl-CoA desaturase ameliorates \u03b1-synuclein cytotoxicity. Cell Rep. 2018;25(10):2742\u201354.e31.","journal-title":"Cell Rep"},{"issue":"5","key":"13_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2019","unstructured":"Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, et al. Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol Cell. 2019;73(5):1001\u201314.e8.","journal-title":"Mol Cell"},{"issue":"6","key":"13_CR27","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177(6):1522\u201335.e14.","journal-title":"Cell"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"608026","DOI":"10.3389\/fcell.2020.608026","volume":"8","author":"CM Bantle","year":"2020","unstructured":"Bantle CM, Hirst WD, Weihofen A, Shlevkov E. Mitochondrial dysfunction in astrocytes: a role in Parkinson\u2019s disease? Front Cell Dev Biol. 2020;8:608026.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"13_CR29","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41593-019-0486-0","volume":"22","author":"AU Joshi","year":"2019","unstructured":"Joshi AU, Minhas PS, Liddelow SA, Haileselassie B, Andreasson KI, Dorn GW 2nd, Mochly-Rosen D. Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration. Nat Neurosci. 2019;22(10):1635\u201348.","journal-title":"Nat Neurosci"},{"issue":"5","key":"13_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nchembio782","volume":"2","author":"DA Bosco","year":"2006","unstructured":"Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth P, et al. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate \u03b1-synuclein fibrilization. Nat Chem Biol. 2006;2(5):249\u201353.","journal-title":"Nat Chem Biol"},{"issue":"5","key":"13_CR31","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/jnr.21191","volume":"85","author":"Y Nakabeppu","year":"2007","unstructured":"Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K. Oxidative damage in nucleic acids and Parkinson\u2019s disease. J Neurosci Res. 2007;85(5):919\u201334.","journal-title":"J Neurosci Res"},{"issue":"4","key":"13_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis. 2013;3(4):461\u201391.","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"13_CR33","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/cells9122623","volume":"9","author":"I Miyazaki","year":"2020","unstructured":"Miyazaki I, Asanuma M. Neuron-astrocyte interactions in Parkinson\u2019s disease. Cells. 2020;9(12):2623.","journal-title":"Cells"},{"issue":"3","key":"13_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0304-3940(96)13217-1","volume":"219","author":"O Kranich","year":"1996","unstructured":"Kranich O, Hamprecht B, Dringen R. Different preferences in the utilization of amino acids for glutathione synthesis in cultured neurons and astroglial cells derived from rat brain. Neurosci Lett. 1996;219(3):211\u20134.","journal-title":"Neurosci Lett"},{"issue":"4","key":"13_CR35","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1046\/j.1471-4159.2000.0741434.x","volume":"74","author":"XF Wang","year":"2000","unstructured":"Wang XF, Cynader MS. Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem. 2000;74(4):1434\u201342.","journal-title":"J Neurochem"},{"issue":"5","key":"13_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/jnr.10042","volume":"66","author":"R Dringen","year":"2001","unstructured":"Dringen R, Gutterer JM, Gros C, Hirrlinger J. Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons. J Neurosci Res. 2001;66(5):1003\u20138.","journal-title":"J Neurosci Res"},{"issue":"3","key":"13_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","volume":"24","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, et al. DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci. 2003;24(3):159\u201360.","journal-title":"Neurol Sci"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"102283","DOI":"10.1016\/j.redox.2022.102283","volume":"51","author":"M Neves","year":"2022","unstructured":"Neves M, Gr\u00e3os M, Anjo SI, Manadas B. Modulation of signaling pathways by DJ-1: an updated overview. Redox Biol. 2022;51:102283.","journal-title":"Redox Biol"},{"issue":"2","key":"13_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/bst0280033","volume":"28","author":"JD Hayes","year":"2000","unstructured":"Hayes JD, Chanas SA, Henderson CJ, McMahon M, Sun C, Moffat GJ, et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans. 2000;28(2):33\u201341.","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"13_CR40","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1523\/JNEUROSCI.23-08-03394.2003","volume":"23","author":"AY Shih","year":"2003","unstructured":"Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci. 2003;23(8):3394\u2013406.","journal-title":"J Neurosci"},{"issue":"10","key":"13_CR41","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1523\/JNEUROSCI.11-10-03070.1991","volume":"11","author":"J Engele","year":"1991","unstructured":"Engele J, Bohn MC. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci. 1991;11(10):3070\u20138.","journal-title":"J Neurosci"},{"issue":"7149","key":"13_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature05957","volume":"448","author":"P Lindholm","year":"2007","unstructured":"Lindholm P, Voutilainen MH, Laur\u00e9n J, Per\u00e4nen J, Lepp\u00e4nen VM, Andressoo JO, et al. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature. 2007;448(7149):73\u20137.","journal-title":"Nature"},{"issue":"30","key":"13_CR43","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0833-09.2009","volume":"29","author":"MH Voutilainen","year":"2009","unstructured":"Voutilainen MH, B\u00e4ck S, P\u00f6rsti E, Toppinen L, Lindgren L, Lindholm P, et al. Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson\u2019s disease. J Neurosci. 2009;29(30):9651\u20139.","journal-title":"J Neurosci"},{"issue":"3","key":"13_CR44","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41380-021-01394-6","volume":"27","author":"P Lindholm","year":"2022","unstructured":"Lindholm P, Saarma M. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Mol Psychiatry. 2022;27(3):1310\u201321.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"13_CR45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/jcm9020456","volume":"9","author":"M Duarte Azevedo","year":"2020","unstructured":"Duarte Azevedo M, Sander S, Tenenbaum L. GDNF, a neuron-derived factor upregulated in glial cells during disease. J Clin Med. 2020;9(2):456.","journal-title":"J Clin Med"},{"issue":"11","key":"13_CR46","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"K Sathe","year":"2012","unstructured":"Sathe K, Maetzler W, Lang JD, Mounsey RB, Fleckenstein C, Martin HL, et al. S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-\u03b1 pathway. Brain. 2012;135(11):3336\u201347.","journal-title":"Brain"},{"issue":"12","key":"13_CR47","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/glia.24254","volume":"70","author":"EA Bancroft","year":"2022","unstructured":"Bancroft EA, De La Mora M, Pandey G, Zarate SM, Srinivasan R. Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons. Glia. 2022;70(12):2330\u201347.","journal-title":"Glia"},{"key":"13_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnagi.2019.00382","volume":"11","author":"A Verma","year":"2020","unstructured":"Verma A, Ravindranath V. CaV1.3 L-type calcium channels increase the vulnerability of substantia Nigra dopaminergic neurons in MPTP mouse model of Parkinson\u2019s disease. Front Aging Neurosci. 2020;11:382.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"13_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12640-011-9271-x","volume":"21","author":"R Wang","year":"2012","unstructured":"Wang R, Ma Z, Wang J, Xie J. L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats. Neurotox Res. 2012;21(3):266\u201370.","journal-title":"Neurotox Res"},{"issue":"7638","key":"13_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"7","key":"13_CR51","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med. 2018;24(7):931\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"13_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","volume":"36","author":"H Lian","year":"2016","unstructured":"Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease. J Neurosci. 2016;36(2):577\u201389.","journal-title":"J Neurosci"},{"key":"13_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2014.00211","volume":"8","author":"R Cabezas","year":"2014","unstructured":"Cabezas R, Avila M, Gonzalez J, El-Bach\u00e1 RS, B\u00e1ez E, Garc\u00eda-Segura LM, et al. Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease. Front Cell Neurosci. 2014;8:211.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"13_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B","volume":"19","author":"Y Hayashi","year":"1997","unstructured":"Hayashi Y, Nomura M, Yamagishi S, Harada S, Yamashita J, Yamamoto H. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia. 1997;19(1):13\u201326.","journal-title":"Glia"},{"issue":"1","key":"13_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat Rev Neurosci. 2006;7(1):41\u201353.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"13_CR56","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","volume":"22","author":"PM Carvey","year":"2005","unstructured":"Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J, Desai BS, et al. 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci. 2005;22(5):1158\u201368.","journal-title":"Eur J Neurosci"},{"issue":"5","key":"13_CR57","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson\u2019s disease. J Cereb Blood Flow Metab. 2015;35(5):747\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"13_CR58","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-023-39038-8","volume":"14","author":"JA de Rus","year":"2023","unstructured":"de Rus JA, Alpaugh M, Denis HL, Tancredi JL, Boutin M, Decaestecker J, et al. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease. Nat Commun. 2023;14(1):3651.","journal-title":"Nat Commun"},{"key":"13_CR59","doi-asserted-by":"publisher","first-page":"812212","DOI":"10.3389\/fphys.2021.812212","volume":"12","author":"EA Bancroft","year":"2022","unstructured":"Bancroft EA, Srinivasan R. Emerging roles for aberrant astrocytic calcium signals in Parkinson\u2019s disease. Front Physiol. 2022;12:812212.","journal-title":"Front Physiol"},{"issue":"10","key":"13_CR60","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41583-020-0361-8","volume":"21","author":"A Semyanov","year":"2020","unstructured":"Semyanov A, Henneberger C, Agarwal A. Making sense of astrocytic calcium signals \u2013 from acquisition to interpretation. Nat Rev Neurosci. 2020;21(10):551\u201364.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"13_CR61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/glia.23531","volume":"67","author":"Y Okubo","year":"2019","unstructured":"Okubo Y, Kanemaru K, Suzuki J, Kobayashi K, Hirose K, Iino M. Inositol 1,4,5-trisphosphate receptor type 2-independent Ca(2+) release from the endoplasmic reticulum in astrocytes. Glia. 2019;67(1):113\u201324.","journal-title":"Glia"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"102383","DOI":"10.1016\/j.ceca.2021.102383","volume":"96","author":"TE Huntington","year":"2021","unstructured":"Huntington TE, Srinivasan R. Astrocytic mitochondria in adult mouse brain slices show spontaneous calcium influx events with unique properties. Cell Calcium. 2021;96:102383.","journal-title":"Cell Calcium"},{"issue":"5","key":"13_CR63","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nn.4001","volume":"18","author":"R Srinivasan","year":"2015","unstructured":"Srinivasan R, Huang BS, Venugopal S, Johnston AD, Chai H, Zeng H, et al. Ca(2+) signaling in astrocytes from Ip3r2(-\/-) mice in brain slices and during startle responses in vivo. Nat Neurosci. 2015;18(5):708\u201317.","journal-title":"Nat Neurosci"},{"key":"13_CR64","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","volume":"9","author":"J Lewerenz","year":"2015","unstructured":"Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front Neurosci. 2015;9:469.","journal-title":"Front Neurosci"},{"key":"13_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-45096-4_1","volume":"13","author":"U Sonnewald","year":"2016","unstructured":"Sonnewald U, Schousboe A. Introduction to the glutamate-glutamine cycle. Adv Neurobiol. 2016;13:1\u20137.","journal-title":"Adv Neurobiol"},{"issue":"22","key":"13_CR66","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.3390\/ijms20225671","volume":"20","author":"AR Malik","year":"2019","unstructured":"Malik AR, Willnow TE. Excitatory amino acid transporters in physiology and disorders of the central nervous system. Int J Mol Sci. 2019;20(22):5671.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"13_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L. Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J Pharmacol Sci. 2020;144(3):151\u201364.","journal-title":"J Pharmacol Sci"},{"key":"13_CR68","doi-asserted-by":"publisher","first-page":"28823","DOI":"10.1038\/srep28823","volume":"6","author":"JM Kim","year":"2016","unstructured":"Kim JM, Cha SH, Choi YR, Jou I, Joe EH, Park SM. DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression. Sci Rep. 2016;6:28823.","journal-title":"Sci Rep"},{"issue":"11","key":"13_CR69","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mds.27077","volume":"32","author":"T Chotibut","year":"2017","unstructured":"Chotibut T, Meadows S, Kasanga EA, McInnis T, Cantu MA, Bishop C, Salvatore MF. Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson\u2019s disease model. Mov Disord. 2017;32(11):1547\u201356.","journal-title":"Mov Disord"},{"issue":"6","key":"13_CR70","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.neuron.2019.12.026","volume":"105","author":"M Corkrum","year":"2020","unstructured":"Corkrum M, Covelo A, Lines J, Bellocchio L, Pisansky M, Loke K, et al. Dopamine-evoked synaptic regulation in the nucleus accumbens requires astrocyte activity. Neuron. 2020;105(6):1036\u201347.e5.","journal-title":"Neuron"},{"issue":"2","key":"13_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41386-018-0151-4","volume":"44","author":"W Xin","year":"2019","unstructured":"Xin W, Schuebel KE, Jair KW, Cimbro R, De Biase LM, Goldman D, Bonci A. Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling. Neuropsychopharmacology. 2019;44(2):344\u201355.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"13_CR72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/hmg\/ddq564","volume":"20","author":"S Schmidt","year":"2011","unstructured":"Schmidt S, Linnartz B, Mendritzki S, Sczepan T, L\u00fcbbert M, Stichel CC, L\u00fcbbert H. Genetic mouse models for Parkinson\u2019s disease display severe pathology in glial cell mitochondria. Hum Mol Genet. 2011;20(6):1197\u2013211.","journal-title":"Hum Mol Genet"},{"key":"13_CR73","doi-asserted-by":"publisher","first-page":"657514","DOI":"10.3389\/fnmol.2021.657514","volume":"14","author":"X Huang","year":"2021","unstructured":"Huang X, Su Y, Wang N, Li H, Li Z, Yin G, et al. Astroglial connexins in neurodegenerative diseases. Front Mol Neurosci. 2021;14:657514.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"13_CR74","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1002\/cphy.c110051","volume":"2","author":"MS Nielsen","year":"2012","unstructured":"Nielsen MS, Axelsen LN, Sorgen PL, Verma V, Delmar M, Holstein-Rathlou NH. Gap junctions. Compr Physiol. 2012;2(3):1981\u20132035.","journal-title":"Compr Physiol"},{"issue":"1","key":"13_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1152\/physrev.00043.2018","volume":"101","author":"C Giaume","year":"2021","unstructured":"Giaume C, Naus CC, S\u00e1ez JC, Leybaert L. Glial connexins and pannexins in the healthy and diseased brain. Physiol Rev. 2021;101(1):93\u2013145.","journal-title":"Physiol Rev"},{"issue":"12","key":"13_CR76","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1073\/pnas.0511118103","volume":"103","author":"MA Retamal","year":"2006","unstructured":"Retamal MA, Cort\u00e9s CJ, Reuss L, Bennett MV, S\u00e1ez JC. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci USA. 2006;103(12):4475\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"13_CR77","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1523\/JNEUROSCI.2042-07.2007","volume":"27","author":"MA Retamal","year":"2007","unstructured":"Retamal MA, Froger N, Palacios-Prado N, Ezan P, S\u00e1ez PJ, S\u00e1ez JC, Giaume C. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci. 2007;27(50):13781\u201392.","journal-title":"J Neurosci"},{"issue":"5","key":"13_CR78","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.0.CO;2-N","volume":"46","author":"M Rufer","year":"1996","unstructured":"Rufer M, Wirth S, Hofer A, Dermietzel R, Pastor A, Kettenmann H, Unsicker K. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated Parkisonian mice. J Neurosci Res. 1996;46(5):606\u201317.","journal-title":"J Neurosci Res"},{"issue":"3","key":"13_CR79","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41418-018-0150-3","volume":"26","author":"L Maatouk","year":"2019","unstructured":"Maatouk L, Yi C, Carrillo-de Sauvage MA, Compagnion AC, Hunot S, Ezan P, et al. Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity. Cell Death Differ. 2019;26(3):580\u201396.","journal-title":"Cell Death Differ"},{"issue":"1","key":"13_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12974-018-1251-0","volume":"15","author":"A Fujita","year":"2018","unstructured":"Fujita A, Yamaguchi H, Yamasaki R, Cui Y, Matsuoka Y, Yamada KI, Kira JI. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson\u2019s disease animal model. J Neuroinflammation. 2018;15(1):227.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"13_CR81","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/glia.23631","volume":"67","author":"EF D\u00edaz","year":"2019","unstructured":"D\u00edaz EF, Labra VC, Alvear TF, Mellado LA, Inostroza CA, Oyarz\u00fan JE, et al. Connexin 43 hemichannels and pannexin-1 channels contribute to the \u03b1-synuclein-induced dysfunction and death of astrocytes. Glia. 2019;67(8):1598\u2013619.","journal-title":"Glia"},{"issue":"2","key":"13_CR82","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nn1623","volume":"9","author":"T Takano","year":"2006","unstructured":"Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X, Nedergaard M. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci. 2006;9(2):260\u20137.","journal-title":"Nat Neurosci"},{"issue":"1","key":"13_CR83","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-023-00102-8","volume":"9","author":"SM Zarate","year":"2023","unstructured":"Zarate SM, Huntington TE, Bagher P, Srinivasan R. Aging reduces calreticulin expression and alters spontaneous calcium signals in astrocytic endfeet of the mouse dorsolateral striatum. NPJ Aging. 2023;9(1):5.","journal-title":"NPJ Aging"},{"issue":"9","key":"13_CR84","doi-asserted-by":"publisher","first-page":"e0162717","DOI":"10.1371\/journal.pone.0162717","volume":"11","author":"C Hoenen","year":"2016","unstructured":"Hoenen C, Gustin A, Birck C, Kirchmeyer M, Beaume N, Felten P, et al. Alpha-synuclein proteins promote pro-inflammatory cascades in microglia: stronger effects of the A53T mutant. PLoS One. 2016;11(9):e0162717.","journal-title":"PLoS One"},{"key":"13_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","volume":"208","author":"P Barkholt","year":"2012","unstructured":"Barkholt P, Sanchez-Guajardo V, Kirik D, Romero-Ramos M. Long-term polarization of microglia upon \u03b1-synuclein overexpression in nonhuman primates. Neuroscience. 2012;208:85\u201396.","journal-title":"Neuroscience"},{"issue":"2","key":"13_CR86","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312.","journal-title":"Neurobiol Dis"},{"key":"13_CR87","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","volume":"317","author":"H Sun","year":"2016","unstructured":"Sun H, Liang R, Yang B, Zhou Y, Liu M, Fang F, et al. Aquaporin-4 mediates communication between astrocyte and microglia: implications of neuroinflammation in experimental Parkinson\u2019s disease. Neuroscience. 2016;317:65\u201375.","journal-title":"Neuroscience"},{"issue":"4","key":"13_CR88","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2020.03.037","volume":"181","author":"P Kitchen","year":"2020","unstructured":"Kitchen P, Salman MM, Halsey AM, Clarke-Bland C, MacDonald JA, Ishida H, et al. Targeting aquaporin-4 subcellular localization to treat central nervous system edema. Cell. 2020;181(4):784\u201399.e19.","journal-title":"Cell"},{"issue":"9","key":"13_CR89","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/ejn.13723","volume":"46","author":"MM Salman","year":"2017","unstructured":"Salman MM, Kitchen P, Woodroofe MN, Brown JE, Bill RM, Conner AC, Conner MT. Hypothermia increases aquaporin 4 (AQP4) plasma membrane abundance in human primary cortical astrocytes via a calcium\/transient receptor potential vanilloid 4 (TRPV4)- and calmodulin-mediated mechanism. Eur J Neurosci. 2017;46(9):2542\u20137.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"13_CR90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","volume":"95","author":"H Chai","year":"2017","unstructured":"Chai H, Diaz-Castro B, Shigetomi E, Monte E, Octeau JC, Yu X, et al. Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence. Neuron. 2017;95(3):531\u2013549.e9.","journal-title":"Neuron"},{"key":"13_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2019.02.019","volume":"126","author":"S Ztaou","year":"2019","unstructured":"Ztaou S, Amalric M. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson\u2019s disease. Neurochem Int. 2019;126:1\u201310.","journal-title":"Neurochem Int"},{"key":"13_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neurobiolaging.2022.12.010","volume":"123","author":"H Bondi","year":"2023","unstructured":"Bondi H, Chiazza F, Masante I, Bortolotto V, Canonico PL, Grilli M. Heterogenous response to aging of astrocytes in murine substantia Nigra pars compacta and pars reticulata. Neurobiol Aging. 2023;123:23\u201334.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"13_CR93","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312\u201325.","journal-title":"Nat Neurosci"},{"issue":"18","key":"13_CR94","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32(18):6391\u2013410.","journal-title":"J Neurosci"},{"issue":"4","key":"13_CR95","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1038\/cddis.2011.17","volume":"2","author":"C Barcia","year":"2011","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Yera D, et al. IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis. 2011;2(4):e142.","journal-title":"Cell Death Dis"},{"issue":"2","key":"13_CR96","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.celrep.2016.12.011","volume":"18","author":"L Soreq","year":"2017","unstructured":"Soreq L, Rose J, Soreq E, Hardy J, Trabzuni D, Cookson MR, et al. Major shifts in glial regional identity are a transcriptional hallmark of human brain aging. Cell Rep. 2017;18(2):557\u201370.","journal-title":"Cell Rep"},{"issue":"29","key":"13_CR97","doi-asserted-by":"publisher","first-page":"e2110746119","DOI":"10.1073\/pnas.2110746119","volume":"119","author":"Y Yang","year":"2022","unstructured":"Yang Y, Song J-J, Choi YR, Kim S-H, Seok M-J, Wulansari N, et al. Therapeutic functions of astrocytes to treat \u03b1-synuclein pathology in Parkinson\u2019s disease. Proc Natl Acad Sci. 2022;119(29):e2110746119.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"13_CR98","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, O\u2019Sullivan K, McCarter R, Bunnage M, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 2003;9(5):589\u201395.","journal-title":"Nat Med"},{"issue":"12","key":"13_CR99","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"WJ Marks Jr","year":"2010","unstructured":"Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, et al. Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010;9(12):1164\u201372.","journal-title":"Lancet Neurol"},{"key":"13_CR100","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fnmol.2018.00165","volume":"11","author":"H Tong","year":"2018","unstructured":"Tong H, Zhang X, Meng X, Lu L, Mai D, Qu S. Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models. Front Mol Neurosci. 2018;11:165.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"13_CR101","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000513678","volume":"28","author":"R-W Du","year":"2021","unstructured":"Du R-W, Bu W-G. Simvastatin prevents neurodegeneration in the MPTP mouse model of Parkinson\u2019s disease via inhibition of A1 reactive astrocytes. Neuroimmunomodulation. 2021;28(2):82\u20139.","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"13_CR102","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2022.3718","volume":"79","author":"KN Stevens","year":"2022","unstructured":"Stevens KN, Creanor S, Jeffery A, Whone A, Zajicek J, Foggo A, et al. Evaluation of simvastatin as a disease-modifying treatment for patients with Parkinson disease: a randomized clinical trial. JAMA Neurol. 2022;79(12):1232\u201341.","journal-title":"JAMA Neurol"}],"container-title":["Advances in Neurobiology","Astrocyte-Neuron Interactions in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-64839-7_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T01:10:38Z","timestamp":1724721038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-64839-7_13"}},"subtitle":["Astrocytes in Parkinson\u2019s Disease"],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031648380","9783031648397"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-64839-7_13","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"28 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}